W2O, a marketing company focused on the health care sector, has acquired Arcus Medica. Specializing in medical and scientific communications, Arcus brings doctoral-level experts to W2O who specialize in translating complex clinical and scientific data to help brands influence key audiences in today’s evolving health care environment.
The acquisition is said to create an integrated communications agency that uses proprietary data and analytics to fuel scientific strategy, peer-to-peer medical engagement and patient-centered narration for clients.
With the integration of Arcus, W2O’s scientific and medical communications team will comprise approximately 40 employees, including 16 doctoral-level experts. Arcus co-founders Mary Seideman, MD, PhD, Stan Eapen, PharmD, and Jonathan Seideman, PhD, will all serve in leadership roles at W2O arcus, which will be an integral part of W2O’s single profit and loss (P&L) operation. They will work closely with W2O’s scientific strategy team run by Ujwal Pyati, PhD, and other multidisciplinary teams across the company to drive differentiated communications and meet diverse client objectives.
Earlier this year, W2O announced its partnership with New York based investment firm New Mountain Capital, enabling the company to support continued growth and accelerated scaling to meet the evolving needs of its clients in an increasingly digital and data-centric world.
Both companies are privately held, and the financial terms of the acquisition are not being disclosed. Delancey Street Partners acted as exclusive financial adviser to Arcus in the transaction.